LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Kodu・Aktsiate loetelu・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Suletud

1.28 2.4

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.22

Max

1.32

Põhinäitajad
By Trading Economics
Sissetulek	17M -26M
Töötajad	171
EBITDA	19M -23M

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	26. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	-34M 68M
Eelmine avamishind	-1.12
Eelmine sulgemishind	1.28

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

1.43 / 1.6 Toetus ja vastupanu

Pliant Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. veebr 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

19. veebr 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19. veebr 2026, 23:39 UTC

Omandamised, ülevõtmised, äriostud

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19. veebr 2026, 23:37 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19. veebr 2026, 23:34 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19. veebr 2026, 23:34 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19. veebr 2026, 23:33 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19. veebr 2026, 23:33 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19. veebr 2026, 22:13 UTC

Market Talk

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19. veebr 2026, 22:08 UTC

Tulu

Fairfax Financial 4Q Rev $8.11B >FFH.T

19. veebr 2026, 22:07 UTC

Tulu

Eldorado Gold 4Q EPS $1.19 >ELD.T

19. veebr 2026, 22:06 UTC

Tulu

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19. veebr 2026, 22:05 UTC

Tulu

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19. veebr 2026, 22:05 UTC

Tulu

Eldorado Gold 4Q Rev $577.2M >ELD.T

19. veebr 2026, 22:04 UTC

Tulu

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19. veebr 2026, 22:04 UTC

Tulu

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19. veebr 2026, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. veebr 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19. veebr 2026, 21:43 UTC

Tulu

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19. veebr 2026, 21:42 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19. veebr 2026, 21:42 UTC

Tulu

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19. veebr 2026, 21:41 UTC

Tulu

Correct: St Barbara 1H Net Loss A$249,000

19. veebr 2026, 21:40 UTC

Tulu

St Barbara 1H Net Loss A$249 Million

19. veebr 2026, 21:39 UTC

Tulu

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19. veebr 2026, 21:37 UTC

Tulu

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19. veebr 2026, 21:37 UTC

Tulu

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Võrdlus sarnastega

Hinnamuutus

Pliant Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Müü

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Pliant Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

1.43 / 1.6Toetus ja vastupanu

Recent bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.